Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), María E. Figueroa(University of Miami), Hugo F. Fernández(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Selina M. Luger(University of Pennsylvania), Igor Dolgalev, Ari Melnick(Cornell University), Adolfo A. Ferrando(Regeneron (United States)), Adriana Heguy, Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Athena M. Cherry(Stanford Health Care), Pieter Van Vlierberghe(Ghent University Hospital), Robert E. Gallagher(Musgrave Park Hospital), Hillard M. Lazarus(University Hospitals of Cleveland), Janis Racevskis(Montefiore Medical Center), Rodney R. Higgins(Abbott Northwestern Hospital), Nicholas D. Socci, Olga Aminova, Mithat Gönen(Memorial Sloan Kettering Cancer Center), Janice Cheng(Genomics (United Kingdom)), Agnès Viale(Genomics (United Kingdom)), Jacob M. Rowe(Technion – Israel Institute of Technology), Rhett P. Ketterling(Mayo Clinic in Arizona), Elisabeth Paietta(Montefiore Medical Center), Kety Huberman, Mark R. Litzow(Mayo Clinic in Arizona), Gail H. Vance(Indiana University Bloomington), Sabrena Thomas, Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Zhuoxin Sun(Dana-Farber Cancer Institute), Marcel R.M. van den Brink(City Of Hope National Medical Center)
Cited by 1,947
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k